Clinical trial Recruiting at 1 site Observational Ages 65 and up

Veterans' views on ketamine therapy for depression and end-of-life issues

Official title: Veteran's Perceptions of Ketamine-Assisted Psychotherapy (KAP) for Depression and End-of-Life

Run by Albany Research Institute, Inc. · NCT06824532 · Data updated 2026-11-12

This study is trying to understand how veterans aged 65 and older feel about using ketamine therapy to help with depression and end-of-life issues.

More Depression trials

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment30 (estimated)
SponsorAlbany Research Institute, Inc.
Academic / other
Locations1 site (Albany, New York)
StatusRecruiting
StartedNovember 8, 2024
Main results expectedMarch 2025
Study endsApril 2025
Registry record updatedFebruary 13, 2025
Trial IDNCT06824532 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are veterans aged 65 and older who are currently enrolled in VA healthcare.

Probably not a fit

Patients who are cognitively impaired to the extent that they cannot comprehend the survey will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the perceptions of veterans aged 65 and older regarding ketamine-assisted psychotherapy (KAP) for depression and end-of-life distress. Participants will be recruited from the VA healthcare system and will engage in interviews where they complete a story about a fictitious veteran facing similar challenges. The study employs a mixed-method design, combining qualitative and quantitative data through interviews and questionnaires to understand veterans' attitudes towards KAP. The findings are intended to inform educational efforts within the VA system regarding the use of KAP.

Why it matters

Potential benefit: If successful, this study could enhance understanding of veterans' perceptions and improve the implementation of ketamine-assisted psychotherapy for those suffering from depression and end-of-life distress.

How similar studies have gone: While this study explores a novel approach to understanding perceptions of KAP among veterans, similar qualitative studies have shown success in other populations regarding mental health interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Veterans enrolled in VA care.
* Age 65 or older.
* Fluent in written and spoken English.

Exclusion Criteria:

* Cognitively impaired to the extent that patient cannot comprehend the survey.

Where it's running

  • Stratton VA Medical Center
    Albany, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Caitlin Holley, Ph.D. — Albany Research Institute, Inc.
  • Study coordinator: Caitlin Holley, Ph.D.
  • Email: caitlin.holley@va.gov
  • Phone: 518-626-5365

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.